Question 1

How many shares of GYRE does WELLS FARGO & COMPANY/MN own?

Accepted Answer

As of 2026-Q2, WELLS FARGO & COMPANY/MN holds 16,297 shares of GYRE (GYRE THERAPEUTICS INC).

Question 2

What is WELLS FARGO & COMPANY/MN's GYRE position worth?

Accepted Answer

As of 2026-Q2, WELLS FARGO & COMPANY/MN's GYRE position is worth $107,397.

Question 3

Is WELLS FARGO & COMPANY/MN buying or selling GYRE?

Accepted Answer

In 2026-Q2, WELLS FARGO & COMPANY/MN increased their GYRE position (+279.9% change in shares).

Question 4

When did WELLS FARGO & COMPANY/MN first buy GYRE?

Accepted Answer

Based on available 13F filings, WELLS FARGO & COMPANY/MN first reported a position in GYRE in 2023-Q4. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	16,297	+279.9%	$107,397	0.0%	$6.59	24
2026-Q1	Decreased	4,290	-66.8%	$29,901	0.0%	$7.90	0
2025-Q4	Increased	12,919	+132.4%	$91,208	0.0%	$7.02	24
2025-Q3	Decreased	5,558	-20.8%	$41,462	0.0%	$7.50	0
2025-Q2	Increased	7,015	+70.8%	$51,560	0.0%	$7.42	21
2025-Q1	Increased	4,108	+2.3%	$31,714	0.0%	$9.11	14
2024-Q4	Increased	4,016	+29.4%	$48,594	0.0%	$12.66	18
2024-Q3	Increased	3,103	+3.9%	$38,912	0.0%	$12.76	14
2024-Q2	Increased	2,987	+3011.5%	$35,635	0.0%	$11.93	22
2024-Q1	Increased	96	+2.1%	$1,678	0.0%	$17.48	8
2023-Q4	New	94	-	$2,415	0.0%	$25.69	19

GYRE11 quarters

GYRE
11 quarters